Looking to push CAR-T in solid tumors, Bay Area biotech goes public in SPAC flip — with slight name change
SPACs might be slowly creeping back.
Monday evening, Estrella Biopharma said it was going public via a SPAC deal with TradeUP Acquisition Corp. The deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
